Access to Medicines for Parkinson's Disease in Kenya: A Qualitative Exploration
Movement Disorders Clinical Practice2024Vol. 11(11), pp. 1373–1378
Citations Over TimeTop 12% of 2024 papers
Abstract
Access to Parkinson's disease medicines in Kenya is limited, with severe implications for symptom management and quality of life. People with Parkinson's disease should be able to access and afford the medicines they need to manage their condition.
Related Papers
- Handbook for Synthesizing Qualitative Research(2006)
- → Advice to People with Parkinson’s in My Clinic: Orthostatic Hypotension(2024)5 cited
- → Usefulness of Parkinson's KinetiGraph in a Parkinson's disease clinic – Survey of 82 patients(2015)3 cited
- PET/SPECTによるParkinson病研究の進歩 (7月第1土曜特集 Parkinson病) -- (Parkinson病の分子病態)(1998)
- 薬剤性Parkinson症候群 (7月第1土曜特集 Parkinson病) -- (Parkinson症候群)(1998)